BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1386050)

  • 21. Effect of chenodeoxycholate and ursodeoxycholate on nucleation time in human gallbladder bile.
    Hirota I; Chijiiwa K; Noshiro H; Nakayama F
    Gastroenterology; 1992 May; 102(5):1668-74. PubMed ID: 1568577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apoptotic activity of novel bile acid derivatives in human leukemic T cells through the activation of caspases.
    Choi YH; Im EO; Suh H; Jin Y; Lee WH; Yoo YH; Kim KW; Kim ND
    Int J Oncol; 2001 May; 18(5):979-84. PubMed ID: 11295044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ursodeoxycholic acid and cholesterol induce enterohepatic cycling of bilirubin in rodents.
    Méndez-Sánchez N; Brink MA; Paigen B; Carey MC
    Gastroenterology; 1998 Sep; 115(3):722-32. PubMed ID: 9721170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of chenodeoxy- and ursodeoxycholic acid on absorption, secretion and permeability in rat colon and small intestine.
    Caspary WF; Meyne K
    Digestion; 1980; 20(3):168-74. PubMed ID: 7390046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthetic bile acid derivatives induce nonapoptotic death of human retinal pigment epithelial cells.
    Yoon HS; Rho JH; Yoo KW; Park WC; Rho SH; Choi YH; Suh H; Kim ND; Yoo KS; Yoo YH
    Curr Eye Res; 2001 May; 22(5):367-74. PubMed ID: 11600938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of mitochondrial dysfunction in combined bile acid-induced cytotoxicity: the switch between apoptosis and necrosis.
    Rolo AP; Palmeira CM; Holy JM; Wallace KB
    Toxicol Sci; 2004 May; 79(1):196-204. PubMed ID: 14976352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytotoxicity of bile salts against biliary epithelium: a study in isolated bile ductule fragments and isolated perfused rat liver.
    Benedetti A; Alvaro D; Bassotti C; Gigliozzi A; Ferretti G; La Rosa T; Di Sario A; Baiocchi L; Jezequel AM
    Hepatology; 1997 Jul; 26(1):9-21. PubMed ID: 9214446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute effects of ursodeoxycholic and chenodeoxycholic acid on the small intestinal absorption of bile acids.
    Stiehl A; Raedsch R; Rudolph G
    Gastroenterology; 1990 Feb; 98(2):424-8. PubMed ID: 2295398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel cytotoxic agents from an unexpected source: bile acids and ovarian tumor apoptosis.
    Horowitz NS; Hua J; Powell MA; Gibb RK; Mutch DG; Herzog TJ
    Gynecol Oncol; 2007 Nov; 107(2):344-9. PubMed ID: 17720233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the effects of bile acids on cell viability and DNA synthesis by rat hepatocytes in primary culture.
    Martinez-Diez MC; Serrano MA; Monte MJ; Marin JJ
    Biochim Biophys Acta; 2000 Feb; 1500(2):153-60. PubMed ID: 10657584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unconjugated bile acids modulate adult and neonatal neutrophil chemotaxis induced in vitro by N-formyl-met-leu-phe-peptide.
    Santoro P; Raimondi F; Annunziata S; Paludetto R; Annella T; Ciccimarra F
    Pediatr Res; 2002 Mar; 51(3):392-6. PubMed ID: 11861947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of ileal bile acid-binding protein expression in Caco-2 cells by ursodeoxycholic acid: role of the farnesoid X receptor.
    Campana G; Pasini P; Roda A; Spampinato S
    Biochem Pharmacol; 2005 Jun; 69(12):1755-63. PubMed ID: 15935148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Evidence for different modes of action on bile acid synthesis.
    Nilsell K; Angelin B; Leijd B; Einarsson K
    Gastroenterology; 1983 Dec; 85(6):1248-56. PubMed ID: 6628924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of bile acids on absorption of nitrendipine in healthy subjects.
    Sasaki M; Maeda A; Sakamoto K; Fujimura A
    Br J Clin Pharmacol; 2001 Dec; 52(6):699-701. PubMed ID: 11736882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitochondrially mediated synergistic cell killing by bile acids.
    Rolo AP; Palmeira CM; Wallace KB
    Biochim Biophys Acta; 2003 Jan; 1637(1):127-32. PubMed ID: 12527417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of the human bile acid UDP-glucuronosyltransferase 1A3 by the farnesoid X receptor and bile acids.
    Erichsen TJ; Aehlen A; Ehmer U; Kalthoff S; Manns MP; Strassburg CP
    J Hepatol; 2010 Apr; 52(4):570-8. PubMed ID: 20189675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of bile acid depletion and of ursodeoxycholic and chenodeoxycholic acids on biliary protein secretion in the hamster.
    Malavolti M; Fromm H; Ceryak S; Shehan KL
    Life Sci; 1990; 46(23):1727-37. PubMed ID: 2355803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of chenodeoxycholic acid (CDCA) and ursodeoxycholic (UDCA) to glucose transport in hamster small intestine in vitro--a study on the mechanism of diarrhea due to CDCA therapy (author's transl)].
    Nakamura T; Ohkuni A; Yamanaka M
    Nihon Shokakibyo Gakkai Zasshi; 1980 Sep; 77(9):1355-61. PubMed ID: 7441911
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative evaluation of chenodeoxycholic and ursodeoxycholic acids in obese patients. Effects on biliary lipid metabolism during weight maintenance and weight reduction.
    Mazzella G; Bazzoli F; Festi D; Ronchi M; Aldini R; Roda A; Grigolo B; Simoni P; Villanova N; Roda E
    Gastroenterology; 1991 Aug; 101(2):490-6. PubMed ID: 2065925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. S-adenosil-L-methionine is able to reverse the immunosuppressive effects of chenodeoxycholic acid in vitro.
    Filaci G; Pelli N; Sacco T; Contini P; Lanza L; Picciotto A; Scudeletti M; Puppo F; Castiglioni G; Indiveri F
    Int J Immunopharmacol; 1997 Mar; 19(3):157-65. PubMed ID: 9306155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.